• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口蹄疫疫苗中140S抗原剂量与牛血清中和抗体反应及诱导的保护水平的相关性

Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.

作者信息

Pay T W, Hingley P J

出版信息

Vaccine. 1987 Mar;5(1):60-4. doi: 10.1016/0264-410x(87)90011-9.

DOI:10.1016/0264-410x(87)90011-9
PMID:3033928
Abstract

An analysis was made of data from potency tests on fifteen batches of monovalent foot-and-mouth disease vaccine, comprising five batches each of type O, type A and type C. Regressions were calculated for the relation of percentage protection (probit) versus log 140S antigen dose and for the serum neutralizing antibody titre (log SN50) versus log 140S antigen dose. Type O vaccines required a far higher level (220 ng) of 140S antigen to achieve a 50% protection level (PA50) in cattle than did type A (2.4 ng) and type C (4.36 ng) vaccines. Type O antigen, dose for dose, was as effective at provoking neutralizing antibody as the types A and C antigens. Thus, it would appear that a far higher log SN50 value (2.14) was required for type O vaccines to equate with 50% protection of cattle than was required for type A (1.17) and type C (1.41) vaccines. Prior to 1977, however, the PA50 value for type O vaccine strain was only 1.34 and it was concluded that an antigenic shift was the most likely cause for the large difference between that value and the current PA50 value.

摘要

对15批单价口蹄疫疫苗效力测试的数据进行了分析,其中包括O型、A型和C型各5批。计算了百分比保护率(概率单位)与log 140S抗原剂量之间的回归关系,以及血清中和抗体滴度(log SN50)与log 140S抗原剂量之间的回归关系。与A型疫苗(2.4纳克)和C型疫苗(4.36纳克)相比,O型疫苗在牛身上达到50%保护水平(PA50)所需的140S抗原水平要高得多(220纳克)。相同剂量下,O型抗原激发中和抗体的效果与A型和C型抗原相同。因此,与A型疫苗(1.17)和C型疫苗(1.41)相比,O型疫苗要达到牛的50%保护水平,似乎需要高得多的log SN50值(2.14)。然而,在1977年之前,O型疫苗株的PA50值仅为1.34,得出的结论是,抗原转变最有可能是该值与当前PA50值存在巨大差异的原因。

相似文献

1
Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.口蹄疫疫苗中140S抗原剂量与牛血清中和抗体反应及诱导的保护水平的相关性
Vaccine. 1987 Mar;5(1):60-4. doi: 10.1016/0264-410x(87)90011-9.
2
Revaccination response of cattle as a function of the 140S foot and mouth disease antigen dose.牛的再次接种反应与140S口蹄疫抗原剂量的关系。
J Comp Pathol. 1984 Jul;94(3):417-24. doi: 10.1016/0021-9975(84)90028-8.
3
Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge.牛口蹄疫疫苗效力试验:抗原剂量、血清中和抗体反应与攻毒保护之间的相互关系。
Vaccine. 1992;10(10):699-706. doi: 10.1016/0264-410x(92)90092-x.
4
A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle.
Vaccine. 1992;10(10):707-13. doi: 10.1016/0264-410x(92)90093-y.
5
The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle.口蹄疫水佐剂疫苗中140S抗原剂量与牛血清抗体反应之间的关系。
J Biol Stand. 1984 Jan;12(1):111-20. doi: 10.1016/s0092-1157(84)80027-x.
6
[Testing the effectiveness of foot-and-mouth disease vaccines: the relationship between test infection results and corresponding neutralization titers of vaccinated cattle].[检测口蹄疫疫苗的有效性:接种疫苗牛的试验感染结果与相应中和滴度之间的关系]
Berl Munch Tierarztl Wochenschr. 1989 Jun 1;102(6):193-8.
7
The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle.利用血清中和抗体检测法测定牛口蹄疫(FMD)疫苗的效力。
Dev Biol Stand. 1986;64:153-61.
8
[The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].[瑞士口蹄疫疫苗的有效性。II. 稳定性问题]
Schweiz Arch Tierheilkd. 1989;131(7):389-95.
9
[The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].
Schweiz Arch Tierheilkd. 1989;131(7):379-86.
10
Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines.
Vaccine. 1994 Jun;12(8):682-6. doi: 10.1016/0264-410x(94)90216-x.

引用本文的文献

1
Cost-effective suspension adaptation of BHK-21 cells for scalable FMD vaccine production in resource-limited settings.
Open Vet J. 2025;15(7):3193-3205. doi: 10.5455/OVJ.2025.v15.i7.30. Epub 2025 Jul 31.
2
Remapping the spatial distribution of neutralizing sites and their immunodominance on the capsid of different topotypes of FMDV serotype O by site-directed competitive ELISA for detection of neutralizing antibodies.通过定点竞争酶联免疫吸附测定法检测中和抗体,重新绘制O型口蹄疫病毒不同拓扑型衣壳上中和位点的空间分布及其免疫显性。
Microbiol Spectr. 2025 Jun 3;13(6):e0334424. doi: 10.1128/spectrum.03344-24. Epub 2025 May 15.
3
Foot-and-mouth disease virus antigenic landscape and reduced immunogenicity elucidated in atomic detail.原子水平解析揭示口蹄疫病毒抗原表位景观和免疫原性降低。
Nat Commun. 2024 Oct 10;15(1):8774. doi: 10.1038/s41467-024-53027-5.
4
Production and Functional Evaluation of Anti- Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D.用突变重组磷脂酶-D免疫家兔产生的抗血清的制备及功能评估。
Biomedicines. 2022 Dec 28;11(1):79. doi: 10.3390/biomedicines11010079.
5
Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination.接种疫苗后通过血清学预测对口蹄疫病毒株的交叉保护作用。
Front Vet Sci. 2022 Dec 1;9:1027006. doi: 10.3389/fvets.2022.1027006. eCollection 2022.
6
Structures of Foot-and-Mouth Disease Virus with Bovine Neutralizing Antibodies Reveal the Determinant of Intraserotype Cross-Neutralization.牛源中和抗体识别的口蹄疫病毒结构揭示了同种型交叉中和的决定因素。
J Virol. 2021 Nov 23;95(24):e0130821. doi: 10.1128/JVI.01308-21. Epub 2021 Sep 29.
7
Efficacy of SAT2 Foot-and-Mouth Disease Vaccines Formulated with Montanide ISA 206B and Quil-A Saponin Adjuvants.用Montanide ISA 206B和Quil-A皂苷佐剂配制的SAT2口蹄疫疫苗的效力
Vaccines (Basel). 2021 Sep 7;9(9):996. doi: 10.3390/vaccines9090996.
8
A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.口蹄疫病毒 O 型 VP1 热诱导突变增强了衣壳稳定性和免疫原性。
J Virol. 2021 Jul 26;95(16):e0017721. doi: 10.1128/JVI.00177-21.
9
Structural and molecular basis for foot-and-mouth disease virus neutralization by two potent protective antibodies.两种强效保护性抗体中和口蹄疫病毒的结构和分子基础
Protein Cell. 2022 Jun;13(6):446-453. doi: 10.1007/s13238-021-00828-9. Epub 2021 Feb 18.
10
Use of Synonymous Deoptimization to Derive Modified Live Attenuated Strains of Foot and Mouth Disease Virus.利用同义去优化法获得口蹄疫病毒的改良减毒活毒株。
Front Microbiol. 2021 Jan 21;11:610286. doi: 10.3389/fmicb.2020.610286. eCollection 2020.